Supporting evidence
Curcumin supplementation × Malondialdehyde (MDA)
- Authoritative support
- 3
- Available studies
- 3
- Unavailable support
- 0
Available supporting studies
Study 1 · Included
Curcumin improves glycemic control and reduces inflammation in T2DM patients
Rct
- Comparison
- Participants received curcumin capsules twice daily for 12 months. · Participants received placebo capsules twice daily for 12 months.
- Duration / follow-up
- 52 weeks
Relevant effects
Absolute change
1.45 · 0.001
Absolute change
1.45 · 0.001
Absolute change
0.11 · 0.001
Study 2 · Included
Curcumin improves liver health in obese diabetes patients
Rct
- Comparison
- Participants received 1500 mg of curcumin daily for 12 months. · Participants received placebo capsules for 12 months.
- Duration / follow-up
- 52 weeks
Relevant effects
Mean difference
1 · 0.001
Mean difference
0.5 · 0.001
Study 3 · Included
Curcumin may improve inflammation and glycemic control in diabetes
Rct
- Comparison
- Participants received 1500 mg/day curcumin supplementation for 12 months. · Participants received a placebo treatment for 12 months.
- Duration / follow-up
- 52 weeks
Relevant effects
Mean difference
0.33 · 0.05
Mean difference
0.65 · 0.001